Literature DB >> 21143600

β1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons.

John Meitzen1, Jessie I Luoma, Christopher M Stern, Paul G Mermelstein.   

Abstract

Monoamine action in the dorsal striatum and nucleus accumbens plays essential roles in striatal physiology. Although research often focuses on dopamine and its receptors, norepinephrine (NE) and adrenergic receptors are also crucial in regulating striatal function. While noradrenergic neurotransmission has been identified in the striatum, little is known regarding the signaling pathways activated by β-adrenergic receptors in this brain region. Using cultured striatal neurons, we characterized a novel signaling pathway by which activation of β1-adrenergic receptors leads to the rapid phosphorylation of cAMP response element binding protein (CREB), a transcription-factor implicated as a molecular switch underlying long-term changes in brain function. NE-mediated CREB phosphorylation requires β1-adrenergic receptor stimulation of a receptor tyrosine kinase, ultimately leading to the activation of a Ras/Raf/MEK/MAPK/MSK signaling pathway. Activation of β1-adrenergic receptors also induces CRE-dependent transcription and increased c-fos expression. In addition, stimulation of β1-adrenergic receptors produces cAMP production, but surprisingly, β1-adrenergic receptor activation of adenylyl cyclase was not functionally linked to rapid CREB phosphorylation. These findings demonstrate that activation of β1-adrenergic receptors on striatal neurons can stimulate two distinct signaling pathways. These adrenergic actions can produce long-term changes in gene expression, as well as rapidly modulate cellular physiology. By elucidating the mechanisms by which NE and β1-adrenergic receptor activation affects striatal physiology, we provide the means to more fully understand the role of monoamines in modulating striatal function, specifically how NE and β1-adrenergic receptors may affect striatal physiology.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21143600      PMCID: PMC3078043          DOI: 10.1111/j.1471-4159.2010.07137.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  77 in total

Review 1.  Integration of signals from receptor tyrosine kinases and g protein-coupled receptors.

Authors:  Vicki L Lowes; Nancy Y Ip; Yung H Wong
Journal:  Neurosignals       Date:  2002 Jan-Feb

Review 2.  Function and regulation of CREB family transcription factors in the nervous system.

Authors:  Bonnie E Lonze; David D Ginty
Journal:  Neuron       Date:  2002-08-15       Impact factor: 17.173

3.  Calmodulin priming: nuclear translocation of a calmodulin complex and the memory of prior neuronal activity.

Authors:  P G Mermelstein; K Deisseroth; N Dasgupta; A L Isaksen; R W Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

4.  Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals.

Authors:  David Weinshenker; Nicole S Miller; Katherine Blizinsky; Marc L Laughlin; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

5.  Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes.

Authors:  Rithwick Rajagopal; Zhe-Yu Chen; Francis S Lee; Moses V Chao
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

6.  On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization.

Authors:  Louk J M J Vanderschuren; Patricia Beemster; Anton N M Schoffelmeer
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

7.  Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins.

Authors:  J Simon C Arthur; Amy L Fong; Jami M Dwyer; Monika Davare; Ed Reese; Karl Obrietan; Soren Impey
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

Review 8.  Noradrenergic mechanisms in neurodegenerative diseases: a theory.

Authors:  Marc R Marien; Francis C Colpaert; Alan C Rosenquist
Journal:  Brain Res Brain Res Rev       Date:  2004-04

9.  Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.

Authors:  J Srinivasan; W J Schmidt
Journal:  Eur J Neurosci       Date:  2003-06       Impact factor: 3.386

10.  Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway.

Authors:  A Pisani; P Bonsi; D Centonze; A Martorana; F Fusco; G Sancesario; C De Persis; G Bernardi; P Calabresi
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

View more
  20 in total

1.  Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.

Authors:  Christopher M Stern; John Meitzen; Paul G Mermelstein
Journal:  Eur J Neurosci       Date:  2011-08-08       Impact factor: 3.386

Review 2.  The biochemical alterations underlying post-burn hypermetabolism.

Authors:  Christopher Auger; Osai Samadi; Marc G Jeschke
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-20       Impact factor: 5.187

3.  A role for repressive histone methylation in cocaine-induced vulnerability to stress.

Authors:  Herbert E Covington; Ian Maze; HaoSheng Sun; Howard M Bomze; Kristine D DeMaio; Emma Y Wu; David M Dietz; Mary Kay Lobo; Subroto Ghose; Ezekiel Mouzon; Rachael L Neve; Carol A Tamminga; Eric J Nestler
Journal:  Neuron       Date:  2011-08-25       Impact factor: 17.173

4.  Palmitoylation of estrogen receptors is essential for neuronal membrane signaling.

Authors:  John Meitzen; Jessie I Luoma; Marissa I Boulware; Valerie L Hedges; Brittni M Peterson; Krista Tuomela; Kyla A Britson; Paul G Mermelstein
Journal:  Endocrinology       Date:  2013-09-05       Impact factor: 4.736

5.  Abnormalities of motor function, transcription and cerebellar structure in mouse models of THAP1 dystonia.

Authors:  Marta Ruiz; Georgina Perez-Garcia; Maitane Ortiz-Virumbrales; Aurelie Méneret; Andrika Morant; Jessica Kottwitz; Tania Fuchs; Justine Bonet; Pedro Gonzalez-Alegre; Patrick R Hof; Laurie J Ozelius; Michelle E Ehrlich
Journal:  Hum Mol Genet       Date:  2015-09-16       Impact factor: 6.150

Review 6.  Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways.

Authors:  John Meitzen; Paul G Mermelstein
Journal:  J Chem Neuroanat       Date:  2011-03-31       Impact factor: 3.052

7.  β-Adrenergic Receptors Regulate the Acquisition and Consolidation Phases of Aversive Memory Formation Through Distinct, Temporally Regulated Signaling Pathways.

Authors:  Hillary C Schiff; Joshua P Johansen; Mian Hou; David E A Bush; Emily K Smith; JoAnna E Klein; Joseph E LeDoux; Robert M Sears
Journal:  Neuropsychopharmacology       Date:  2016-10-20       Impact factor: 7.853

8.  Enhanced striatal β1-adrenergic receptor expression following hormone loss in adulthood is programmed by both early sexual differentiation and puberty: a study of humans and rats.

Authors:  John Meitzen; Adam N Perry; Christel Westenbroek; Valerie L Hedges; Jill B Becker; Paul G Mermelstein
Journal:  Endocrinology       Date:  2013-03-26       Impact factor: 4.736

Review 9.  Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviors.

Authors:  Karl T Schmidt; David Weinshenker
Journal:  Mol Pharmacol       Date:  2014-02-05       Impact factor: 4.436

10.  The organizational and aromatization hypotheses apply to rapid, nonclassical hormone action: neonatal masculinization eliminates rapid estradiol action in female hippocampal neurons.

Authors:  John Meitzen; Danielle D Grove; Paul G Mermelstein
Journal:  Endocrinology       Date:  2012-08-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.